Glial cells as targets for cytotoxic immune mediators
- PMID: 11596128
- DOI: 10.1002/glia.1109
Glial cells as targets for cytotoxic immune mediators
Abstract
Oligodendrocytes and Schwann cells are the glia principally responsible for the synthesis and maintenance of myelin. Damage may occur to these cells in a number of conditions, but perhaps the most studied are the idiopathic inflammatory demyelinating diseases, multiple sclerosis in the CNS, and Guillain-Barré syndrome and its variants in the peripheral nervous system (PNS). This article explores the effects on these cells of cytotoxic immunological and inflammatory mediators: similarities are revealed, of which perhaps the most important is the sensitivity of both Schwann cells and oligodendrocytes to many such agents. This area of research is, however, characterised and complicated by numerous and often very substantial inter-observer discrepancies. Marked variability in cell culture techniques, and in assays of cell damage and death, provide artifactual explanations for some of this variability; true inter-species differences also contribute. Not the least important conclusion centres on the limited capacity of in vitro studies to reveal disease mechanisms: cell culture findings merely illustrate possibilities which must then be tested ex vivo using human tissue samples affected by the relevant disease.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
EAE, EAN and galactocerebroside sera bind to oligodendrocytes and Schwann cells.J Neurol Sci. 1980 Nov;48(2):287-96. doi: 10.1016/0022-510x(80)90207-5. J Neurol Sci. 1980. PMID: 7000981
-
[Antibodies to myelin cerebrosides and their role in the pathogenesis of autoimmune demyelinating diseases (review)].Zh Nevropatol Psikhiatr Im S S Korsakova. 1985;85(12):1863-72. Zh Nevropatol Psikhiatr Im S S Korsakova. 1985. PMID: 3911691 Review. Russian. No abstract available.
-
Complement mediated serum cytotoxicity against oligodendrocytes: a comparison with other cells of the oligodendrocyte-type 2 astrocyte lineage.J Neurol Sci. 1990 Jul;97(2-3):155-62. doi: 10.1016/0022-510x(90)90214-8. J Neurol Sci. 1990. PMID: 2205708
-
Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology.Curr Opin Neurol. 2007 Jun;20(3):294-8. doi: 10.1097/WCO.0b013e32813aee7f. Curr Opin Neurol. 2007. PMID: 17495623 Review.
-
[Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].Rinsho Shinkeigaku. 2010 Nov;50(11):788-93. doi: 10.5692/clinicalneurol.50.788. Rinsho Shinkeigaku. 2010. PMID: 21921443 Review. Japanese.
Cited by
-
Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamed white matter in an animal model of multiple sclerosis.J Neurosci Res. 2005 Jun 15;80(6):798-808. doi: 10.1002/jnr.20474. J Neurosci Res. 2005. PMID: 15898103 Free PMC article.
-
Astrocytes are an early target in osmotic demyelination syndrome.J Am Soc Nephrol. 2011 Oct;22(10):1834-45. doi: 10.1681/ASN.2010111127. Epub 2011 Sep 1. J Am Soc Nephrol. 2011. PMID: 21885671 Free PMC article.
-
Effect of Fasudil on remyelination following cuprizone-induced demyelination.CNS Neurosci Ther. 2020 Jan;26(1):76-89. doi: 10.1111/cns.13154. Epub 2019 May 23. CNS Neurosci Ther. 2020. Retraction in: CNS Neurosci Ther. 2020 Jul;26(7):778. doi: 10.1111/cns.13393. PMID: 31124292 Free PMC article. Retracted.
-
Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.J Neuroophthalmol. 2017 Sep;37(3):291-299. doi: 10.1097/WNO.0000000000000508. J Neuroophthalmol. 2017. PMID: 28410278 Free PMC article. Review. No abstract available.
-
Glial Factors Regulating White Matter Development and Pathologies of the Cerebellum.Neurochem Res. 2020 Mar;45(3):643-655. doi: 10.1007/s11064-020-02961-z. Epub 2020 Jan 23. Neurochem Res. 2020. PMID: 31974933 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources